# Prospective Open-label Evaluation of Cenobamate Adjunctive Treatment of Adults With Refractory Focal Epilepsy

> **NCT04879433** · — · UNKNOWN · sponsor: **Mid-Atlantic Epilepsy and Sleep Center, LLC** · enrollment: 100 (estimated)

## Conditions studied

- Focal Epilepsy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04879433
- **Lead sponsor:** Mid-Atlantic Epilepsy and Sleep Center, LLC
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-25
- **Primary completion:** 2023-06-25
- **Final completion:** 2023-11-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04879433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04879433, "Prospective Open-label Evaluation of Cenobamate Adjunctive Treatment of Adults With Refractory Focal Epilepsy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04879433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
